New drug ahead in weight loss
A new study has revealed that the drug tirzepatide outperforms other obesity medications in weight reduction, helping individuals without diabetes lose more than 20% of their body weight. It surpasses semaglutide and liraglutide in effectiveness. Researchers explained that tirzepatide's superiority is due to its dual mechanism of action, which activates both the GLP-1 hormone and the gastrointestinal hormone, enhancing its efficacy in weight loss. The results indicate that newer medications like tirzepatide achieve better outcomes; however, weight loss may not be sustained after stopping treatment.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading